admin

31
May

How Drug Shortage in the US is a Win-Win for India

India Ratings and Research (Ind-Ra) projects that US-focused pharmaceutical companies

30
May

PharmaLinkage: Fueling Innovation and Expansion in the Pharmaceutical Industry

In today’s fast-paced pharmaceutical industry, finding suitable manufacturing facilities for APIs, formulations, and CDMOs can be a daunting task. Amidst the complexities of global sourcing, PharmaLinkage.com emerges as a beacon of simplification, offering a comprehensive solution for all pharmaceutical manufacturing sourcing needs. Let’s delve deeper into how PharmaLinkage can revolutionize your organization’s approach to manufacturing partnerships and propel growth within

Read more

29
May

India Ranks Second Globally in Pharma Market Growth Potential

India has secured a notable achievement in the global APIs market competition,

28
May

Small-Molecule Drugs Continue to Dominate New Drug Approvals

In 2023, the US Food and Drug Administration’s Center for Drug Evaluation and Research

28
May

Unveiling the Future: Exploring the Potential of APIs

The future of Active Pharmaceutical Ingredients (APIs) holds significant promise and challenges

27
May

Key Market Developments in the Generic Drugs Segment

In 2023, generic-drug approvals in the US surged to a recent peak, although the number of

27
May

Sustainable Growth: Green API Production’s Impact on India’s Market

In the realm of pharmaceuticals, green is emerging as the new standard

26
May

The Evolution of APIs Amidst the COVID-19 Pandemic

The active pharmaceutical ingredients (API) market witnessed

26
May

Forecasting 2024: What Lies Ahead for CDMOs/CMOs?

The landscape for Contract Development and Manufacturing Organizations

25
May

The Emergence of India’s API Market

The global pharmaceutical sector is extensive, encompassing two primary segments: Active Pharmaceutical